IGA AIZIGOV: Open Payments
NPI 1992155121 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 10 payments from 7 companies in 2025. Trend: 2023 $125 · 2024 $581 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $250 |
| Lundbeck LLC | 2 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: Auvelity, VYEPTI, CAPLYTA, REXULTI, INGREZZA, ARISTADA, LOREEV XR, VRAYLAR.
Industry payments across IN — which companies pay providers there.
